Publications
By Year
Now showing items 681-700 of 5027 records
Metabolic phenotyping of BMI to characterize cardiometabolic risk: evidence from large population-based cohorts.
Habtamu B Beyene; Corey Giles; Kevin Huynh; Tingting Wang; Michelle Cinel; Natalie A Mellett; Gavriel Olshansky; Thomas G Meikle; Gerald F Watts; Joseph Hung; Jennie Hui; Gemma Cadby; John Beilby; John Blangero; Eric K Moses; Jonathan E Shaw; Dianna J Magliano; Peter J Meikle
NATURE COMMUNICATIONS - 07 Oct 2023
Obesity is a risk factor for type 2 diabetes and cardiovascular disease. However, a substantial proportion of patients with these conditions have a seemingly normal body mass index (BMI). Conversely, not all obese individuals present with metabolic disorders giving rise to the concept of "metabolically healthy obese". We use lipidomic-based models for BMI to calculate a metabolic BMI score (mBM...
Enhancing the Detection and Care of Heterozygous Familial Hypercholesterolemia in Primary Care: Cost-Effectiveness and Return on Investment.
Clara Marquina; Jedidiah Morton; Tom Brett; Melanie Lloyd; Jan Radford; Clare Heal; Charlotte Hespe; Gerard Gill; David Sullivan; Ella Zomer; Ian Li; Jing Pang; Gerald F Watts; Zanfina Ademi
CIRCULATION. GENOMIC AND PRECISION MEDICINE - 12 Apr 2023
Heterozygous familial hypercholesterolemia (HeFH) is under-detected and undertreated. A general practitioner-led screening and care program for HeFH effectively identified and managed patients with HeFH. We evaluated the cost-effectiveness and the return on investment of an enhanced-care strategy for HeFH in primary care in Australia.We developed a multistate Markov model to estimate the outcom...
Phenotyping the hypertensive heart.
Marijana Tadic; Cesare Cuspidi; Thomas H Marwick
EUROPEAN HEART JOURNAL - 11 Oct 2022
Arterial hypertension remains the most frequent cardiovascular (CV) risk factor, and is responsible for a huge global burden of disease. Echocardiography is the first-line imaging method for the evaluation of cardiac damage in hypertensive patients and novel techniques, such as 2D and D speckle tracking and myocardial work, provide insight in subclinical left ventricular (LV) impairment that wo...
Adverse Impact of Peri-Procedural Stroke in Patients Who Underwent Percutaneous Coronary Intervention.
Noah Z Wexler; Sara Vogrin; Angela L Brennan; Samer Noaman; Omar Al-Mukhtar; Kawa Haji; Jason E Bloom; Diem T Dinh; Wayne C Zheng; James A Shaw; Stephen J Duffy; Jeffrey Lefkovits; Christopher M Reid; Dion Stub; David M Kaye; Nicholas Cox; William Chan
THE AMERICAN JOURNAL OF CARDIOLOGY - 15 Oct 2022
Peri-procedural stroke (PPS) is an important complication in patients who underwent percutaneous coronary intervention (PCI). The extent to which PPS impacts mortality and outcomes remains to be defined. Consecutive patients who underwent PCI enrolled in the Victorian Cardiac Outcomes Registry (2014 to 2018) were categorized into PPS and no PPS groups. The primary outcome was 30-day major adver...
Prognosis and Personalized In Silico Prediction of Treatment Efficacy in Cardiovascular and Chronic Kidney Disease: A Proof-of-Concept Study.
Mayra Alejandra Jaimes Campos; Iván Andújar; Felix Keller; Gert Mayer; Peter Rossing; Jan A Staessen; Christian Delles; Joachim Beige; Griet Glorieux; Andrew L Clark; William Mullen; Joost P Schanstra; Antonia Vlahou; Kasper Rossing; Karlheinz Peter; Alberto Ortiz; Archie Campbell; Frederik Persson; Agnieszka Latosinska; Harald Mischak; Justyna Siwy; Joachim Jankowski
PHARMACEUTICALS (BASEL, SWITZERLAND) - 14 Sep 2023
(1) Background: Kidney and cardiovascular diseases are responsible for a large fraction of population morbidity and mortality. Early, targeted, personalized intervention represents the ideal approach to cope with this challenge. Proteomic/peptidomic changes are largely responsible for the onset and progression of these diseases and should hold information about the optimal means of treatment an...
Study protocol for development and validation of a single tool to assess risks of stroke, diabetes mellitus, myocardial infarction and dementia: DemNCD-Risk.
Scherazad Kootar; Md Hamidul Huque; Kim M Kiely; Craig S Anderson; Louisa Jorm; Miia Kivipelto; Nicola T Lautenschlager; Fiona Matthews; Jonathan E Shaw; Rachel A Whitmer; Ruth Peters; Kaarin J Anstey
BMJ OPEN - 22 Sep 2023
Current efforts to reduce dementia focus on prevention and risk reduction by targeting modifiable risk factors. As dementia and cardiometabolic non-communicable diseases (NCDs) share risk factors, a single risk-estimating tool for dementia and multiple NCDs could be cost-effective and facilitate concurrent assessments as compared with a conventional single approach. The aim of this study is to ...
Impact of Mood Disorder History and Bone Health on Cognitive Function Among Men Without Dementia.
Kanika Mehta; Mohammadreza Mohebbi; Julie A Pasco; Lana J Williams; Ken Walder; Boon Lung Ng; Veer Bala Gupta
JOURNAL OF ALZHEIMER'S DISEASE : JAD - 25 Sep 2023
Poor cognitive function, a major disabling condition of older age, is often considered a prodromal feature of dementia. High mortality and the lack of a cure for dementia have necessitated a focus on the identification of potentially modifiable risk factors. Mental and physical health conditions such as mood disorders and bone loss have been previously linked with poor cognition individually al...
Return to play after myocarditis: time to abandon the one-size-fits-all approach?
Guido Claessen; André La Gerche; Ruben De Bosscher
BRITISH JOURNAL OF SPORTS MEDICINE - 01 Oct 2023
The T1D Index: Implications of Initial Results, Data Limitations, and Future Development.
Graham D Ogle; Gabriel A Gregory; Fei Wang; Thomas Ig Robinson; Jayanthi Maniam; Dianna J Magliano; Trevor John Orchard
CURRENT DIABETES REPORTS - 01 Oct 2023
Current global information on incidence, prevalence, and mortality of type 1 diabetes (T1D) is limited, particularly in low- and middle-income countries. To address this gap in evidence, JDRF, Life for a Child, International Society for Pediatric and Adolescent Diabetes, and International Diabetes Federation have developed the T1D Index, which uses a Markov mathematical model, and machine learn...
Clinimetrics: Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-Fatigue).
Tegan Ilsley; Erin J Howden
JOURNAL OF PHYSIOTHERAPY - 01 Oct 2023
A two-point strategy to clarify prognosis in >80 year olds experiencing out of hospital cardiac arrest.
Elizabeth D Paratz; Emily Nehme; Natalie Heriot; Kenneth Bissland; Stephanie Rowe; Louise Fahy; David Anderson; Dion Stub; Andre La Gerche; Ziad Nehme
RESUSCITATION - 01 Oct 2023
The global population is aging, with the number of ≥80-year-olds projected to triple over the next 30 years. Rates of out-of-hospital cardiac arrest (OHCA) are also increasing within this age group.The Victorian Ambulance Cardiac Arrest Registry was utilised to identify OHCAs in patients aged ≥80 years between 2002-2021. Predictors of survival to discharge were defined and a prognostic score de...
Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality.
; Christina Magnussen; Francisco M Ojeda; Darryl P Leong; Jesus Alegre-Diaz; Philippe Amouyel; Larissa Aviles-Santa; Dirk De Bacquer; Christie M Ballantyne; Antonio Bernabé-Ortiz; Martin Bobak; Hermann Brenner; Rodrigo M Carrillo-Larco; James de Lemos; Annette Dobson; Marcus Dörr; Chiara Donfrancesco; Wojciech Drygas; Robin P Dullaart; Gunnar Engström; Marco M Ferrario; Jean Ferrières; Giovanni de Gaetano; Uri Goldbourt; Clicerio Gonzalez; Guido Grassi; Allison M Hodge; Kristian Hveem; Licia Iacoviello; M Kamran Ikram; Vilma Irazola; Modou Jobe; Pekka Jousilahti; Pontiano Kaleebu; Maryam Kavousi; Frank Kee; Davood Khalili; Wolfgang Koenig; Anna Kontsevaya; Kari Kuulasmaa; Karl J Lackner; David M Leistner; Lars Lind; Allan Linneberg; Thiess Lorenz; Magnus Nakrem Lyngbakken; Reza Malekzadeh; Sofia Malyutina; Ellisiv B Mathiesen; Olle Melander; Andres Metspalu; J Jaime Miranda; Marie Moitry; Joseph Mugisha; Mahdi Nalini; Vijay Nambi; Toshiharu Ninomiya; Karen Oppermann; Eleonora d'Orsi; Andrzej Pająk; Luigi Palmieri; Demosthenes Panagiotakos; Arokiasamy Perianayagam; Annette Peters; Hossein Poustchi; Andrew M Prentice; Eva Prescott; Ulf Risérus; Veikko Salomaa; Susana Sans; Satoko Sakata; Ben Schöttker; Aletta E Schutte; Sadaf G Sepanlou; Sanjib Kumar Sharma; Jonathan E Shaw; Leon A Simons; Stefan Söderberg; Abdonas Tamosiunas; Barbara Thorand; Hugh Tunstall-Pedoe; Raphael Twerenbold; Diego Vanuzzo; Giovanni Veronesi; Julia Waibel; S Goya Wannamethee; Masafumi Watanabe; Philipp S Wild; Yao Yao; Yi Zeng; Andreas Ziegler; Stefan Blankenberg
THE NEW ENGLAND JOURNAL OF MEDICINE - 05 Oct 2023
Five modifiable risk factors are associated with cardiovascular disease and death from any cause. Studies using individual-level data to evaluate the regional and sex-specific prevalence of the risk factors and their effect on these outcomes are lacking.We pooled and harmonized individual-level data from 112 cohort studies conducted in 34 countries and 8 geographic regions participating in the ...
Effect of High-Intensity Power Training on Cognitive Function in Older Adults With Type 2 Diabetes: Secondary Outcomes of the GREAT2DO Study.
Ren Ru Zhao; Yorgi Mavros; Jacinda Meiklejohn; Kylie A Anderberg; Nalin Singh; Shelley Kay; Michael K Baker; Yi Wang; Mike Climstein; Anthony O'Sullivan; Nathan De Vos; Bernhard T Baune; Steven N Blair; David Simar; Maria A Fiatarone Singh
THE JOURNALS OF GERONTOLOGY. SERIES A, BIOLOGICAL SCIENCES AND MEDICAL SCIENCES - 06 Oct 2022
We sought to determine the effects of 12 months of power training on cognition, and whether improvements in body composition, muscle strength, and/or aerobic capacity (VO2peak) were associated with improvements in cognition in older adults with type 2 diabetes (T2D). Participants with T2D were randomized to power training or low-intensity sham exercise control condition, 3 days per week for 12 ...
A plasma protein signature associated with cognitive function in men without severe cognitive impairment.
Kanika Mehta; Mohammadreza Mohebbi; Julie A Pasco; Lana J Williams; Sophia X Sui; Ken Walder; Boon Lung Ng; Veer Bala Gupta
01 Sep 2023
A minimally invasive blood-based assessment of cognitive function could be a promising screening strategy to identify high-risk groups for the incidence of Alzheimer's disease.The study included 448 cognitively unimpaired men (mean age 64.1 years) drawn from the Geelong Osteoporosis Study. A targeted mass spectrometry-based proteomic assay was performed to measure the abundance levels of 269 pl...
Measurement of stress-induced sympathetic nervous activity using multi-wavelength PPG.
Radhagayathri Udhayakumar; Saifur Rahman; Dilpreet Buxi; Vaughan G Macefield; Tye Dawood; Nicholas Mellor; Chandan Karmakar
ROYAL SOCIETY OPEN SCIENCE - 01 Aug 2023
The onset of stress triggers sympathetic arousal (SA), which causes detectable changes to physiological parameters such as heart rate, blood pressure, dilation of the pupils and sweat release. The objective quantification of SA has tremendous potential to prevent and manage psychological disorders. Photoplethysmography (PPG), a non-invasive method to measure skin blood flow changes, has been us...
Editorial: Novel biomarkers and extracellular vesicles in endocrine hypertension and related disorders.
Cristian A Carvajal; Morag J Young; Damian G Romero
FRONTIERS IN ENDOCRINOLOGY - 01 Jan 2023
Vitamin D supplementation for improving bone density in vitamin D-deficient children and adolescents: systematic review and individual participant data meta-analysis of randomized controlled trials.
Feitong Wu; Ghada El-Hajj Fuleihan; Guoqi Cai; Christel Lamberg-Allardt; Heli T Viljakainen; Maya Rahme; Ida M Grønborg; Rikke Andersen; Anuradha Khadilkar; Mughal M Zulf; Christian Mølgaard; Anni Larnkjær; Kun Zhu; Richard D Riley; Tania Winzenberg
01 Sep 2023
Vitamin D supplements are widely used for improving bone health in children and adolescents, but their effects in vitamin D-deficient children are unclear.This study aimed to examine whether the effect of vitamin D supplementation on bone mineral density (BMD) in children and adolescents differs by baseline vitamin D status and estimate the effect in vitamin D-deficient individuals.This is a sy...
Increased intracellular miR-142 in adults with Type 1 diabetes.
Li Huang; Andrzej S Januszewski; Yusuke Takahashi; David N O'Neal; Jian-Xing Ma; Alicia J Jenkins
JOURNAL OF DIABETES AND ITS COMPLICATIONS - 25 Aug 2023
microRNAs (miRs), including miR-142, modulate gene expression and processes implicated in vascular damage and may serve as therapeutic targets and agents, including in Type 1 diabetes (T1D). The project aimed to assess whether miR-142 levels differ between people with and without T1D, and to analyse miR-142 associations with cardiovascular (CVD) risk factors. Intracellular miRs were isolated fr...
Physical Activity Assessed by Wrist and Thigh Worn Accelerometry and Associations with Cardiometabolic Health.
Benjamin D Maylor; Charlotte L Edwardson; Alexandra M Clarke-Cornwell; Melanie J Davies; Nathan P Dawkins; David W Dunstan; Kamlesh Khunti; Tom Yates; Alex V Rowlands
SENSORS (BASEL, SWITZERLAND) - 23 Aug 2023
Physical activity is increasingly being captured by accelerometers worn on different body locations. The aim of this study was to examine the associations between physical activity volume (average acceleration), intensity (intensity gradient) and cardiometabolic health when assessed by a thigh-worn and wrist-worn accelerometer. A sample of 659 office workers wore an Axivity AX3 on the non-domin...
Socioeconomic status and diabetes technology use in youth with type 1 diabetes: a comparison of two funding models.
Kate E Lomax; Craig E Taplin; Mary B Abraham; Grant J Smith; Aveni Haynes; Ella Zomer; Katrina L Ellis; Helen Clapin; Sophia Zoungas; Alicia J Jenkins; Jenny Harrington; Martin I de Bock; Timothy W Jones; Elizabeth A Davis
FRONTIERS IN ENDOCRINOLOGY - 01 Jan 2023
Technology use, including continuous glucose monitoring (CGM) and insulin pump therapy, is associated with improved outcomes in youth with type 1 diabetes (T1D). In 2017 CGM was universally funded for youth with T1D in Australia. In contrast, pump access is primarily accessed through private health insurance, self-funding or philanthropy. The study aim was to investigate the use of diabetes tec...
Show more...